Ziprasidone Market Size Share Trends Growth Demand and Competitive Analysis Insights 2022-2029 | DataM Intelligence

October 13 19:16 2022
Ziprasidone Market Size Share Trends Growth Demand and Competitive Analysis Insights 2022-2029 | DataM Intelligence
DataM Intelligence
The Global Ziprasidone Market is estimated to reach a high CAGR during the forecast period (2022-2029).

Market Overview:

The Ziprasidone Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR during the forecast period (2022-2029).

Ziprasidone, normally called Geodon, is an odd antipsychotic of the second generation this is used to treat schizophrenia and bipolar disorder, amongst other things. The pills encompass hydrochloride salt and ziprasidone hydrochloride, which rebalances dopamine and serotonin within the brain to improve temper and conduct.

To Download free sample @ Click Here

Market Dynamics

The growing prevalence of intellectual disorders international is predicted to drive marketplace increase.

According to the World Health Organization, Schizophrenia causes psychosis, is related to large incapacity and may have an effect on all regions of existence, along with private, own family, social, educational, and occupational functioning. Schizophrenia impacts around 24 million human beings globally or one in each three hundred people (zero.32 percentage).

Adults have a charge of 1 in 222 (zero.45 percent). It isn’t as massive as many other mental ailments. Therefore, the demand for the medicine has improved because of an increase in positive mental health situations, that are largely dealt with with Ziprasidone.

Furthermore, the medication is recommended because of the immediate effect visible whilst turning in the dose, ensuing in on the spot alleviation. Moreover, Dr. Reddy’s announced the release of Ziprasidone Mesylate on March 17, 2020, intending to make healthcare greater affordable with the aid of giving cost to the drugstore. Thus, from the above statements, the market is predicted to force in the forecast period.

Market Segmentation:

By Route of Administration

  • Oral Capsules
  • Intramuscular Injection
  • Others

By Application

By Distribution Channel

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Others

Competitive Landscape

Major key players in the ziprasidone market are Pfizer Inc., Sandoz AG, Lupin Pharmaceuticals, Inc., Mylan Pharmaceuticals, Apotex, Dr. Reddy’s laboratories Ltd., Wockhardt, Aurobindo Pharma USA.

Trending Topics

Undifferentiated Pleomorphic Sarcoma Therapeutics Market

Cutaneous Squamous Cell Carcinoma Market

Media Contact
Company Name: DataM Intelligence
Contact Person: Sai
Email: Send Email
Phone: +1 877 441 4866
Country: United States